Medicine and Dentistry
Glioblastoma
100%
Ganglioglioma
53%
Neoplasm
53%
Recurrent Disease
30%
Overall Survival
28%
Intracranial Tumor
28%
Brain Metastasis
28%
Radiation Therapy
23%
Clinical Trial
23%
Magnetic Resonance Imaging
20%
Biological Marker
19%
Stereotactic Radiosurgery
17%
Systematic Review
16%
Progression Free Survival
16%
Meta-Analysis
16%
Central Nervous System
16%
Malignant Neoplasm
14%
Diseases
13%
Brain Biopsy
12%
Biopsy Technique
12%
Temozolomide
11%
Neurologic Disease
11%
Isocitrate Dehydrogenase
10%
Tumor Progression
9%
Progenitor Cell
9%
Tumor Recurrence
9%
Tumor Cell
9%
Tumor Microenvironment
8%
Immunotherapy
8%
Meningioma
8%
Bleeding
8%
Treatment Effect
7%
Moyamoya Disease
7%
Craniotomy
7%
Pharmacodynamics
7%
Radiation Necrosis
7%
Oligodendrocyte
6%
Cerebrospinal Fluid
6%
Hazard Ratio
6%
P21
5%
Neurosurgery
5%
Cancer Therapy
5%
Neuro-Oncology
5%
Reoperation
5%
Demyelination
5%
Blood Brain Barrier
5%
Glioma Cell
5%
Pontine Glioma
5%
Diffuse Large B-Cell Lymphoma
5%
Central Nervous System Tumor
5%
Keyphrases
Glioblastoma
82%
Glioma
41%
High-grade Glioma
32%
Tumor
28%
Overall Survival
22%
Meta-analysis
20%
Microdialysis
20%
Clinical Trials
19%
Recurrent Glioblastoma
18%
Stereotactic Radiosurgery
17%
Radiotherapy
17%
Senolytics
16%
Radiation Effects
15%
Neurological Diseases
15%
Isocitrate Dehydrogenase 1 (IDH1)
15%
Stem Cells
14%
Brain Metastases
13%
Cellular Senescence
12%
Temozolomide
12%
Senescence
12%
Brain Biopsy
12%
Chemotherapy
12%
Central Nervous System
12%
Microperfusion
11%
Operative
11%
Neurodegenerative Diseases
11%
Progression-free Survival
11%
IDH mutation
11%
Brain Tumor
11%
Metabolomics
11%
Neurogenesis
11%
Irradiation
11%
Blood-brain Barrier
11%
Tumor Recurrence
10%
Microglia
10%
Extent of Resection
9%
Senescent Cells
9%
Neuroregeneration
9%
National Cancer Database
9%
Glioblastoma Cells
9%
Clinical Presentation
8%
Systematic Meta-analysis
8%
Germline Variants
8%
Primary Brain Tumor
8%
Treatment Effect
8%
Radiation Therapy
8%
Multipotent Stem Cells
8%
IDH-wildtype
8%
Senescence-associated Secretory Phenotype
8%
Tumor Growth
8%